DRIO Share Price Performance
US$13.91
-0.78 (-5.28%)
82.6% undervalued intrinsic discount
US$80.00
Fair Value
Price US$13.91
AnalystHighTarget US$80.00
AnalystConsensusTarget US$19.75
AnalystLowTarget US$12.00
Fair ValueUS$80.00
Share Pricen/a
DarioHealth Corp. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
DRIO Community Narratives
AN
Fair Value US$80 82.6% undervalued intrinsic discount
Aging Demographics And Telehealth Will Transform Chronic Care
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$19.75 29.6% undervalued intrinsic discount
DRIO: New Client Wins And Pricing Initiatives Will Drive Upside Potential
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value US$12 15.9% overvalued intrinsic discount
Digital Health Onboarding Delays And Rising Costs Will Ease Eventually
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
DRIO: New Client Wins And Pricing Initiatives Will Drive Upside Potential
Key Takeaways Shifting focus to high-margin recurring revenue and expanding into digital chronic care markets, with strong early traction in new platform segments. AI-driven operational efficiencies and signed large health plan deals set the stage for improved profitability and accelerated revenue growth in coming years.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$19.75
29.6% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
11.4% p.a.
Profit Margin
7.11%
Future PE
84.65x
Share price in 2028
US$13.83
Aging Demographics And Telehealth Will Transform Chronic Care
Key Takeaways Industry-leading outcomes, platform expansion, and entry into new care verticals position DarioHealth for accelerated market share and significant long-term revenue growth. Broad AI integration and premium-based reimbursement unlock major operating efficiencies and new revenue streams, driving margin expansion and improved earnings visibility.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$80
82.6% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
21.97% p.a.
Profit Margin
8.77%
Future PE
51.32x
Share price in 2028
US$44.34
Digital Health Onboarding Delays And Rising Costs Will Ease Eventually
Key Takeaways Persistent onboarding delays and client turnover risk short-term revenue, while macroeconomic uncertainty and enterprise budget constraints may limit new customer growth. Margin gains via AI and analytics are offset by the need for sustained R&D investment and sector challenges that delay profitability and consistent earnings growth.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$12
15.9% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
9.54% p.a.
Profit Margin
8.77%
Future PE
10.62x
Share price in 2028
US$6.65
Recently Updated Narratives
AN
DRIO: New Client Wins And Pricing Initiatives Will Drive Upside Potential
Fair Value: US$19.75 29.6% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Digital Health Onboarding Delays And Rising Costs Will Ease Eventually
Fair Value: US$12 15.9% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Aging Demographics And Telehealth Will Transform Chronic Care
Fair Value: US$80 82.6% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
DarioHealth Corp. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -5.02
- 68.09%
- -137.45%
- 40.9%
About DRIO
- Founded
- 2011
- Employees
- 199
- CEO
- WebsiteView website
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
